AB Soft ii manual

5.Cowan DT, Wilson-Barnett J, Griffiths P, Vaughan DJ, Gondhia A, Allan LG. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med 6(2): 113-121, 3/2005.

6.Galer BS, Sheldon E, Patel N, Codding C, Burch F, Gammaitoni AR. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opin 20(9):

1455-1458, 9/2004.

7.Gammaitoni AR, Galer BS, Lacouture P, Domingos J, Schlagheck T. Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain. Pain Med 4(1): 21-30, 3/2003.

8.Gerber L, el-Gabalawy H, Arayssi T, Furst G, Yarboro C, Schumacher HR. Polyarticular arthritis, independent of rheumatoid factor, is associated with poor functional outcome in recent onset inflammatory synovitis. Journal of Back and Musculoskeletal Rehabilitation 14(3): 105-109, 2000.

9.Gerber LH, Furst G, Yarboro C, el-Gabalawy H. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis. Clin Exp Rheumatol 21(5 Suppl 31): S65-S70, 9/2003.

10.Gimbel J, Linn R, Hale M, Nicholson B. Lidocaine patch treatment in patients with low back pain: results of an open- label, nonrandomized pilot study. Am J Ther 12(4): 311-319, 7/2005.

11.Gorodetskyi IG, Gorodnichenko AI, Tursin PS, Reshetnyak VK, Uskov ON. Non-invasive interactive neurostimulation in the post-operative recovery of patients with a trochanteric fracture of the femur. Journal of Bone and Joint Surgery-British Volume 89B(11): 1488-1494, 11/2007.

12.Gould E, Ma T. Back pain. Archives of Physical Medicine and Rehabilitation 87(11): e38, 11/2006.

13.Kapstad H, Hanestad BR, Langeland N, Rustoen T, Stavem K. Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgery. BMC Musculoskelet Disord 9(1): 55, 4/2008.

14.Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int 19(1): 57-63, 1/2008.

15.Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int 19(1): 57-63, 1/2008.

16.Markenson JA, Croft J, Zhang PG, Richards P. Treatment of persistent pain associated with osteoarthritis with controlled- release oxycodone tablets in a randomized controlled clinical trial. Clin J Pain 21(6): 524-535, 11/2005.

17.McDonald C, Wilson M, Todd J. 686 Butrans (Buprenorphine) Transdermal Patches Improve Quality of Life in patients with Osteoarthritis(OA). European Journal of Pain 10(Supplement 1): S179, 9/2006.

18.Mystakidou K, Parpa E, Tsilika E, Mavromati A, Smyrniotis V, Georgaki S, Vlahos L. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J Pain 4(6): 298-306, 8/2003.

19.Pavelka K, Le L, X, Bjorneboe O, Herrero-Beaumont G, Richarz U. Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control. Curr Med Res Opin 20(12): 1967- 1977, 12/2004.

20.Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, Colucci SV, Richards P. Long-term Use of Controlled-release Oxycodone for Noncancer Pain: Results of a 3-year Registry Study. Clin J Pain 23(4): 287-299, 5/2007.

21.Rosenthal M, Moore P, Groves E, Iwan T, Schlosser LG, Dziewanowska Z, Negro-Vilar A. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA):

43 44